Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,161,310 papers from all fields of science
Search
Sign In
Create Free Account
Protein Farnesylation
Known as:
C-terminal protein farnesylation
, Farnesylation, Protein
, protein amino acid farnesylation
OBSOLETE. The covalent or non-covalent attachment of a farnesyl group to the carboxy terminus of a protein. [GOC:jl]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Protein Prenylation
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Burn-induced muscle metabolic derangements and mitochondrial dysfunction are associated with activation of HIF-1α and mTORC1: Role of protein farnesylation
Harumasa Nakazawa
,
K. Ikeda
,
+13 authors
M. Kaneki
Scientific Reports
2017
Corpus ID: 32869045
Metabolic derangements are a clinically significant complication of major trauma (e.g., burn injury) and include various aspects…
Expand
2008
2008
SCH66336, inhibitor of protein farnesylation, blocks signal transducer and activators of transcription 3 signaling in lung cancer and interacts with a small molecule inhibitor of epidermal growth…
A. Dowlati
,
A. Kluge
,
D. Nethery
,
B. Halmos
,
J. Kern
Anti-Cancer Drugs
2008
Corpus ID: 12956236
Signal transducer and activators of transcription 3 (STAT3) is an important transcription factor that is essential for lung…
Expand
2006
2006
In vitro and in vivo analysis of the role of Pex19p farnesylation and Pex14p phosphorylation in peroxisome biogenesis
Ilse Vastiau
2006
Corpus ID: 88235194
2005
2005
Tools to analyze protein farnesylation in cells.
J. Troutman
,
M. J. Roberts
,
D. Andres
,
H. Spielmann
Bioconjugate chemistry
2005
Corpus ID: 30359709
Farnesylation of proteins is catalyzed by protein farnesyl transferase (FTase) and is obligatory for the function of the…
Expand
2004
2004
Getting a handle on protein farnesylation
M. Eisenstein
Nature Methods
2004
Corpus ID: 43836994
A new technique based on the Staudinger ligation has enabled researchers to conduct a broad analysis of cellular targets of…
Expand
2003
2003
Phase I I a nd P harmacodynamic S tudy o f t he Farnesyltransfer ase I nhibitor R 115777 a s I nitial T herapy i n Patients W ith M etastatic P ancreatic A denocarcinoma
S. Cohen
,
L. Ho
,
+12 authors
N. Meropol
2003
Corpus ID: 78827533
Purpose: R115777 is a selective nonpeptidomimetic inhibitor of farnesyltransferase (FTase), one of several enzymes responsible…
Expand
1999
1999
Characterization of the Ras homologue of Schistosoma mansoni.
A. Osman
,
E. G. Niles
,
P. LoVerde
Molecular and biochemical parasitology (Print)
1999
Corpus ID: 22273647
Highly Cited
1998
Highly Cited
1998
Lovastatin inhibits proliferation of pancreatic cancer cell lines with mutant as well as with wild-type K-ras oncogene but has different effects on protein phosphorylation and induction of apoptosis.
C. Müller
,
A. Bockhorn
,
+4 authors
O. Koch
International Journal of Oncology
1998
Corpus ID: 28965350
Besides its pharmacological effect on cholesterol biosynthesis, lovastatin inhibits p21ras proteins by substrate depletion for…
Expand
1998
1998
Antiapoptotic signaling by the insulin receptor in Chinese hamster ovary cells.
W. Lee‐Kwon
,
D. Park
,
P. Baskar
,
S. Kole
,
M. Bernier
Biochemistry
1998
Corpus ID: 26096246
We have sought to determine whether insulin can promote cell survival and protect Chinese hamster ovary (CHO) cells from…
Expand
1997
1997
Geranylgeraniol potentiates lovastatin inhibition of oncogenic H-Ras processing and signaling while preventing cytotoxicity
T. Mcguire
,
S. Sebti
Oncogene
1997
Corpus ID: 24098223
Oncogenic H-Ras requires farnesylation for its transforming activity. Lovastatin inhibits both protein farnesylation and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE